Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Elevation Oncology, Inc. (ELEV) since 2022 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Elevation Oncology, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1783032.
Total stock buying since 2022: $0.
Total stock sales since 2022: $2,898,087.
Total stock option exercises since 2022: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 0 | $0 | 83,003 | $0 |
| 2024 | 0 | $0 | 0 | $0 | 52,049 | $0 |
| 2023 | 0 | $0 | 0 | $0 | 50,251 | $0 |
| 2022 | 0 | $0 | 702,737 | $2,898,087 | 75,373 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-06 | 0 | $0 | 0 | $0 | 12,560 | $0 |
| 2025-05 | 0 | $0 | 0 | $0 | 8,893 | $0 |
| 2025-02 | 0 | $0 | 0 | $0 | 61,550 | $0 |
| 2024-12 | 0 | $0 | 0 | $0 | 12,563 | $0 |
| 2024-11 | 0 | $0 | 0 | $0 | 300 | $0 |
| 2024-09 | 0 | $0 | 0 | $0 | 12,562 | $0 |
| 2024-06 | 0 | $0 | 0 | $0 | 12,562 | $0 |
| 2024-05 | 0 | $0 | 0 | $0 | 300 | $0 |
| 2024-03 | 0 | $0 | 0 | $0 | 12,562 | $0 |
| 2024-02 | 0 | $0 | 0 | $0 | 1,200 | $0 |
| 2023-12 | 0 | $0 | 0 | $0 | 12,563 | $0 |
| 2023-09 | 0 | $0 | 0 | $0 | 12,562 | $0 |
| 2023-06 | 0 | $0 | 0 | $0 | 12,563 | $0 |
| 2023-03 | 0 | $0 | 0 | $0 | 12,563 | $0 |
| 2022-12 | 0 | $0 | 0 | $0 | 12,562 | $0 |
| 2022-09 | 0 | $0 | 0 | $0 | 12,562 | $0 |
| 2022-06 | 0 | $0 | 0 | $0 | 50,249 | $0 |
| 2022-05 | 0 | $0 | 702,737 | $2,898,087 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-16 | Ferra Joseph J Jr (CHIEF EXECUTIVE OFFICER) | Option Ex | 12,560 | .00 | 0 |
| 2025-05-15 | Furlong Tammy (CHIEF FINANCIAL OFFICER) | Option Ex | 2,643 | .00 | 0 |
| 2025-05-15 | Ferra Joseph J Jr (CHIEF EXECUTIVE OFFICER) | Option Ex | 6,250 | .00 | 0 |
| 2025-02-15 | Furlong Tammy (CHIEF FINANCIAL OFFICER) | Option Ex | 9,675 | .00 | 0 |
| 2025-02-15 | Jansen Valerie Malyvanh (CHIEF MEDICAL OFFICER) | Option Ex | 17,500 | .00 | 0 |
| 2025-02-15 | Dornan David (CHIEF SCIENTIFIC OFFICER) | Option Ex | 9,375 | .00 | 0 |
| 2025-02-15 | Ferra Joseph J Jr (CHIEF EXECUTIVE OFFICER) | Option Ex | 25,000 | .00 | 0 |
| 2024-12-16 | Ferra Joseph J Jr (CHIEF EXECUTIVE OFFICER) | Option Ex | 12,563 | .00 | 0 |
| 2024-11-15 | Furlong Tammy (CHIEF FINANCIAL OFFICER) | Option Ex | 300 | .00 | 0 |
| 2024-09-16 | Ferra Joseph J Jr (CHIEF EXECUTIVE OFFICER) | Option Ex | 12,562 | .00 | 0 |
| 2024-06-16 | Ferra Joseph J Jr (CHIEF EXECUTIVE OFFICER) | Option Ex | 12,562 | .00 | 0 |
| 2024-05-15 | Furlong Tammy (CHIEF FINANCIAL OFFICER) | Option Ex | 300 | .00 | 0 |
| 2024-03-16 | Ferra Joseph J Jr (CHIEF EXECUTIVE OFFICER) | Option Ex | 12,562 | .00 | 0 |
| 2024-02-15 | Furlong Tammy (CHIEF FINANCIAL OFFICER) | Option Ex | 1,200 | .00 | 0 |
| 2023-12-16 | Ferra Joseph J Jr (CHIEF EXECUTIVE OFFICER) | Option Ex | 12,563 | .00 | 0 |
| 2023-09-16 | Ferra Joseph J Jr (CHIEF EXECUTIVE OFFICER) | Option Ex | 12,562 | .00 | 0 |
| 2023-06-16 | Ferra Joseph J Jr (INTERIM CEO & CFO) | Option Ex | 12,563 | .00 | 0 |
| 2023-03-16 | Ferra Joseph J Jr (INTERIM CEO & CFO) | Option Ex | 12,563 | .00 | 0 |
| 2022-12-16 | Ferra Joseph J Jr (CHIEF FINANCIAL OFFICER) | Option Ex | 12,562 | .00 | 0 |
| 2022-09-16 | Ferra Joseph J Jr (CHIEF FINANCIAL OFFICER) | Option Ex | 12,562 | .00 | 0 |
| 2022-06-16 | Ferra Joseph J Jr (CHIEF FINANCIAL OFFICER) | Option Ex | 50,249 | .00 | 0 |
| 2022-05-25 | Royston Aaron | Sale | 702,737 | 4.12 | 2,898,087 |
Insider trading activities including stock purchases, stock sales, and option exercises of ELEV listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Elevation Oncology, Inc. (symbol ELEV, CIK number 1783032) see the Securities and Exchange Commission (SEC) website.